4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide,
NU 6140,
NU-6140,
NU6140,
Cdk2 Inhibitor IV, NU6140,
444723-13-1,
NU6140,
NU 6140,
CHEMBL1802728,
4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide,
4-{[6-(cyclohexylmethoxy)-7H-purin-2-yl]amino}-N,N-diethylbenzamide,
Cdk2 inhibitor IV,
GTPL5949,
SCHEMBL2169233,
CTK8E7940,
DTXSID30436732,
HMS3229E18,
BDBM50347924,
IN1369,
ZINC22309248,
AKOS024457537,
CCG-206836,
NCGC00370819-01,
NU6140, >=98% (HPLC),
RT-011957,
4-(6-cyclohexylmethoxy-9hpurin-2-ylamino)-N,N-diethyl-benzamide,
4-[[6-(Cyclohexylmethoxy)-1H-purin-2-yl]amino]-N,N-diethylbenzamide,
AQG,
D04WFN,
XHEQSRJCJTWWAH-UHFFFAOYSA-N,
NU-6140,
CID10202471,
C506606,